We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ZEO:NASDAQZeo Energy Corporation Analysis

Data as of 2026-07-31 - not real-time

$0.58

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Zeo Energy Corp. is trading just above its recent support level while the short‑term moving average remains below the mid‑term average, confirming a bearish price alignment. The relative strength index hovers around the neutral zone, suggesting limited upward momentum, yet the MACD line has crossed above its signal, offering a tentative bullish signal despite both lines staying in negative territory. Volume has been on a downtrend, and the 30‑day price volatility is exceptionally high, amplifying the risk of sharp moves. A beta well above the market and a historic drawdown of nearly eighty percent further underscore the stock’s sensitivity to market swings. Fundamentally, the company posts negative operating and profit margins, cash‑flow deficits, and a debt‑to‑equity ratio that signals leverage concerns, while its book value per share is negative, leading to a deeply negative price‑to‑book multiple.
The solar residential sector is inherently policy‑driven and capital‑intensive, adding medium to high regulatory and sector risk, though geographic exposure is limited to the United States, keeping currency risk low. Market sentiment is in an “extreme greed” phase, which may be inflating price expectations despite the distressed fundamentals. Consequently, the stock appears cheap on a price‑to‑sales basis but suffers from severe profitability and balance‑sheet weaknesses, making the overall risk profile high and the upside potential constrained without a clear turnaround.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • price near technical support with bearish SMA alignment
  • decreasing volume and extreme volatility
  • negative margins and cash‑flow deficits

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • potential upside from MACD bullish crossover
  • high beta may amplify market rebounds
  • sector growth prospects if policy support improves

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • valuation appears cheap relative to sales
  • ongoing structural challenges in profitability
  • need for balance‑sheet restructuring to reduce leverage

Key Metrics & Analysis

Financial Health

Revenue Growth50.10%
Profit Margin-15.13%
ROE-29.34%
ROA-13.17%
Debt/Equity2.76
P/B Ratio-10.5
Op. Cash Flow$-7280825
Free Cash Flow$-8946159
Industry P/E32.9

Technical Analysis

TrendBearish
RSI47.0
Support$0.50
Resistance$0.70
MA 20$0.57
MA 50$0.69
MA 200$0.99
MACDBullish
VolumeDecreasing
Fear & Greed Index91.59

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta1.90
Volatility67.17%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.